Medicamen Biotech Share Price

₹ 267.80

+₹5.65 (2.16%)
1D
Last updated 04 Nov, 2026, 15:22 IST
NSE: MEDICAMEQ
|
Pharmaceuticals

Medicamen Biotech Share Price Today

As of 4 Nov 2026, Medicamen Biotech share price is ₹267.80. The stock opened at ₹258.95, compared to its previous close of ₹262.15. During today's trading session, Medicamen Biotech share price moved in the range of ₹254.00 to ₹267.80, with an average price of ₹260.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹212.40 and a high of ₹447.65. On the performance front, Medicamen Biotech share price has increased by 1.96% over the last six months and is down 31.56% on a year-on-year basis.

Share price over the last 1 day rose from 255.00 to 267.80, ranging between 254.05 and 267.80.
₹254.00
2.16% up today
₹267.80
1D LOW
1D HIGH

Medicamen Biotech Stock Insights

Latest Earning
Op Profit TrendUp by 21.26% YoY
Latest Earning
Net Profit TrendUp by 49.39% YoY
Latest Earning
Revenue TrendUp by 19.01% YoY
Stock Performance
OutperformingBeat Nifty by 11.13 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 5.23%
Shareholding Pattern
FIIFII decreased stake by 3.19%
Medicamen Biotech stock performance
Open₹258.95
High₹267.80
Low₹254.00
Prev. close₹262.15
Medicamen Biotech trading activity
Volume10,373
Average traded price₹258.39
Last traded time03:22:55 04 Nov
Last traded quantity100
Circuit
L
H
₹249.05
₹275.25
52-week
L
H
₹212.40
₹447.65
Mkt Cap Cr
368.87
P/E
36.74
P/B
1.26
ROA
2.7%
ROE
3.5%
ROCE
4.79%
Quick Ratio
1.75
EV/EBITDA
16.82

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Medicamen Biotec has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Medicamen Biotec appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Medicamen Biotec earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,25,150.1638.74.769.61%13.79%18.65%2.3122.17
Divis Laboratories2,64,141.2491.0315.8914.6%15.32%19.56%3.559.98
Torrent Pharmaceuticals1,76,300.5084.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,25,352.4494.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.914.568.57%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,351.2041.442.954.79%7.21%8.58%1.3518.91
Cipla1,11,647.7239.413.186.6%8.18%10.8%2.521.15
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma97,756.7126.352.586.34%9.25%11.76%1.1512.4
Lupin91,300.8316.574.114.47%23.76%24.88%1.429.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Medicamen Biotech Company Background

ISIN
INE646B01010
Sector Market Cap
₹ 368.87 Cr

Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.

Medicamen Biotech Financial Highlights

  • Revenue: Medicamen Biotech reported revenue of ₹200.88 crore in FY26 vs ₹168.79 crore in FY25. It showed an increase of 19.01% on a yearly basis.
  • Operating Profit: Medicamen Biotech reported an operating profit of ₹11.98 crore in FY26 vs ₹9.88 crore in FY25. It showed an increase of 21.26% on a year-on-year basis.
  • Net Profit: Medicamen Biotech reported a net profit of ₹9.80 crore in FY26 vs ₹6.56 crore in FY25. It showed an increase of 49.39% on a yearly basis.

Medicamen Biotech Quarterly Result Highlights

  • Medicamen Biotech reported revenue of ₹48.76 crore in Jun 2026, compared with ₹62.39 crore in Mar 2026, representing a decrease of 21.85% on a quarter-on-quarter (QoQ) basis.
  • Medicamen Biotech reported an operating profit of ₹2.57 crore in Jun 2026, compared with ₹5.06 crore in Mar 2026, representing a decrease of 49.21% on a quarter-on-quarter (QoQ) basis.
  • Medicamen Biotech reported a profit of ₹1.85 crore in Jun 2026, compared with ₹4.45 crore in Mar 2026, reflecting a decrease of 58.43% on a QoQ basis.
  • The earnings per share (EPS) of Medicamen Biotech stood at ₹7.22 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
42.57%
FII
4.35%
Other DII
0.00%
Retail and other
53.08%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.10%
Jun 20260.07%
Sep 20264.49%
Oct 20264.35%

Medicamen Biotech Investment Returns

1 day
+0.38%
1 week
+3.50%
1 month
-17.40%
1 year
-31.56%
3 years
-59.70%
5 years
-62.34%

Medicamen Biotech Share Price History

Medicamen Biotech share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹263.60 / ₹262.15
+0.79%
02 Nov 26
₹254.00 / ₹260.10
+1.52%
30 Oct 26
₹269.75 / ₹256.20
-4.03%
29 Oct 26
₹258.90 / ₹266.95
+5.00%
Show more

Medicamen Biotech Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹197.77₹162.55₹179.31₹140.87
Other Income₹3.11₹6.24₹2.33₹2.46
Total Revenue₹200.88₹168.79₹181.63₹143.33
Total Expenses₹188.90₹158.91₹168.56₹126.28
Profit Before Tax₹11.98₹9.88₹13.08₹17.05
Tax₹2.19₹3.32₹3.58₹2.32
Profit After Tax₹9.80₹6.56₹9.49₹14.73
EPS - Basic₹7.22₹5.16₹8.63₹11.64
EPS - Diluted₹7.22₹5.16₹8.63₹11.64

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹9.80₹6.56₹9.49₹14.73
Income before WC changes₹20.96₹19.44₹23.84₹25.61
Change in Assets-₹44.70-₹17.53-₹21.45-₹29.22
Change in Liabilities-₹7.43-₹8.71-₹6.07₹0.44
Change in WC-₹52.13-₹26.25-₹27.52-₹28.78
Cash flow from Operations-₹33.17-₹8.16-₹6.74-₹6.29
Cash flow from Investing-₹3.04-₹1.40-₹5.56-₹5.88
Cash flow from Financing₹63.72-₹1.47₹6.31₹29.13
Total Cash Flow₹27.50-₹11.03-₹5.99₹16.95
Cash (Start of the year)₹3.76₹14.79₹20.78₹3.82
Cash (End of the year)₹31.26₹3.76₹14.79₹20.78

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹148.25₹132.60₹134.96₹115.15
Current Assets₹223.73₹164.55₹159.59₹163.36
Total Assets₹371.99₹297.15₹294.55₹278.52
Current Liabilities₹87.92₹78.16₹84.56₹82.57
Net Current Asset₹135.81₹86.39₹75.04₹80.79
Non-Current Liabilities₹8.52₹5.94₹3.01₹2.53
Equity Capital₹275.55₹213.05₹206.98₹193.41
Total Equity & Liabilities₹371.99₹297.15₹294.55₹278.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹178.85₹151.46₹172.39₹137.88
Other Income₹3.10₹6.23₹2.30₹2.46
Total Revenue₹181.95₹157.69₹174.69₹140.35
Total Expenses₹170.40₹144.91₹157.80₹123.01
Profit Before Tax₹11.55₹12.77₹16.89₹17.33
Tax₹2.14₹3.33₹3.59₹2.33
Profit After Tax₹9.41₹9.45₹13.30₹15.00
EPS - Basic₹6.94₹7.43₹10.50₹12.04
EPS - Diluted₹6.94₹7.43₹10.50₹12.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹9.41₹9.45₹13.30₹15.00
Income before WC changes₹19.66₹22.28₹27.56₹25.90
Change in Assets-₹40.89-₹12.84-₹17.14-₹34.31
Change in Liabilities-₹8.02-₹12.08-₹7.60₹1.79
Change in WC-₹48.92-₹24.92-₹24.74-₹32.52
Cash flow from Operations-₹29.26-₹2.63-₹0.25-₹3.50
Cash flow from Investing-₹2.85-₹1.72-₹8.71-₹7.54
Cash flow from Financing₹59.61-₹6.68₹3.14₹27.67
Total Cash Flow₹27.50-₹11.04-₹5.82₹16.63
Cash (Start of the year)₹3.58₹14.62₹20.44₹3.81
Cash (End of the year)₹31.08₹3.58₹14.62₹20.44

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹155.40₹139.68₹141.84₹118.81
Current Assets₹206.12₹153.51₹152.37₹157.97
Total Assets₹361.52₹293.19₹294.21₹276.78
Current Liabilities₹78.65₹72.58₹82.30₹80.46
Net Current Asset₹127.47₹80.93₹70.07₹77.51
Non-Current Liabilities₹3.14₹2.97₹2.71₹2.53
Equity Capital₹279.73₹217.64₹209.21₹193.80
Total Equity & Liabilities₹361.52₹293.19₹294.21₹276.78
* All values are in INR Crore
Medicamen Biotech market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Medicamen Biotech technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
40.58
Neutral
ATR (14)
14.09
Neutral
STOCH(9,6)
55.95
Neutral
STOCH RSI (14)
68.22
Neutral
ADX(9)
53.42
Bearish
UO(9)
51.05
Neutral
ROC(12)
-11.01
Bearish
WillR(14)
-73.89
Neutral
Period
Simple value
Exponential vaue
5D
259.93
261.18
10D
260.95
265.28
20D
279.26
274.97
50D
287.37
279.19
100D
263
273.84
Volume trend — traded volume by day
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Medicamen Biotech
Pharmaceuticals
Add Stock
Add Another

Medicamen Biotech Returns Calculator

Ex-date: 18 Sep 2026

Top Gainers

SAREGAMA Share Price
₹636.80
+74.6 (+13.27%)
APLLTD Share Price
₹906.70
+103.9 (+12.94%)
GMDCLTD Share Price
₹469.20
+43.6 (+10.24%)
ZEEL Share Price
₹67.87
+6.2 (+10.05%)
REDINGTON Share Price
₹366.75
+31.5 (+9.4%)
See more

Top Losers

SKFINDIA Share Price
₹1395.30
-76.6 (-5.2%)
AIAENG Share Price
₹3219.80
-169.9 (-5.01%)
MTARTECH Share Price
₹6036.50
-276 (-4.37%)
ZYDUSLIFE Share Price
₹1188.10
-52.5 (-4.23%)
ALKYLAMINE Share Price
₹1589.50
-69.3 (-4.18%)
See more

Medicamen Biotech Share Price FAQs

Please be aware that Medicamen Biotech stock prices are subject to continuous fluctuations due to various factors.